This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa
Menu
Book
DAY ONE WATCH LIVE (EST); 19/10/20keyboard_arrow_right

DAY ONE WATCH LIVE (EST); 19/10/20

search

DAY ONE WATCH LIVE (EST); 19/10/20

search
This agenda is just the start. Wherever you are in the world, the Cell Therapy Bioprocessing & Commercialization and Cell Therapy Manufacturing & Gene Therapy Congresses are coming to you. The talks listed here are just the tip of the iceberg. Please also make sure to browse all of our 'on-demand' sessions which available to watch at your convenience.
7:25am - 7:30am5 mins
Cell Therapy
Welcome from Sarah Lintern - Conference Organizer
    7:25am - 7:30am5 mins
    Gene Edited Ex Vivo Cell Therapy
    Welcome from Sarah Lintern - Conference Organizer
      7:25am - 7:30am5 mins
      In Vivo Gene Therapy
      Welcome from Sarah Lintern - Conference Organizer
        7:25am - 7:30am5 mins
        Advanced Tools for Cell and Tissue Manufacturing: 20/20 View
        Welcome from Sarah Lintern - Conference Organizer
          7:30am - 7:50am20 mins
          Cell Therapy
          Data Governance and Data Integrity as a framework during Process Development
          • Sara Levy - CSV & Data integrity Manager, Pluristem Therapeutics Inc.
          7:30am - 7:50am20 mins
          Gene Edited Ex Vivo Cell Therapy
          Senti Bio Case Study: Gene Modified Allogeneic MSCs and NK Cells
          • Philip Lee - COO and Co-Founder, Senti Biosciences
          7:30am - 7:50am20 mins
          In Vivo Gene Therapy
          Next Generation Cell Line Development & Large-Scale Bioprocessing Technology
          • Sam Wadsworth - Chief Scientific Officer, Ultragenyx Gene Therapy
          7:30am - 7:50am20 mins
          Advanced Tools for Cell and Tissue Manufacturing: 20/20 View
          Scalable, Consistent, Cost-effective Manufacturing for Tissues and Organs
          • Mary Clare McCorry - Director, Technology and Process Development, Advanced Regenerative Manufacturing Institute (ARMI)
          7:50am - 8:15am25 mins
          Cell Therapy
          Speaker Q&A - Cell Therapy Process Development
          • Lior Raviv - Vice President, Pluristem Therapeutics Inc.
          • Sara Levy - CSV & Data integrity Manager, Pluristem Therapeutics Inc.
          • Mustafa Munye - Lead Scientist, Cell and Gene Therapy Catapult
          7:50am - 8:15am25 mins
          Gene Edited Ex Vivo Cell Therapy
          Speaker Q&A - Auto vs. Allo Manufacturing & Infrastructure
          • Geoffrey Hodge - Chief Technical Officer, Unum Therapeutics
          • Gregory Russotti - Chief Technology Officer, Century Therapeutics LLC, USA
          7:50am - 8:15am25 mins
          In Vivo Gene Therapy
          Speaker Q&A - High Throughput Applications in Production Platforms & Enabling Manufacturing Tech
          • Sam Wadsworth - Chief Scientific Officer, Ultragenyx Gene Therapy
          • Thomas Kreil - Vice President, Global Pathogen Safety, Takeda
          • Rachel Legmann - Director, Gene Therapy & Viral Vectors, Pall Corporation
          • Jayanthi Grebin - Senior Business Development Manager CGT, CPC - Colder Products Company, USA
          7:50am - 8:15am25 mins
          Advanced Tools for Cell and Tissue Manufacturing: 20/20 View
          The Importance of High Quality Raw Materials for Developing your Cell or Gene-Modified Cell Therapy: A Master Cell Bank Case Study
          • Benjamin Fryer - Founder, Pluristyx, Incorporated, USA
          8:15am - 9:00am45 mins
          Cell Therapy
          Exhibition Viewing Time & Live Labs
            8:15am - 9:00am45 mins
            Gene Edited Ex Vivo Cell Therapy
            Exhibition Viewing Time & Live Labs
              8:15am - 9:00am45 mins
              In Vivo Gene Therapy
              Exhibition Viewing Time & Live Labs
                8:15am - 9:00am45 mins
                Advanced Tools for Cell and Tissue Manufacturing: 20/20 View
                Exhibition Viewing Time & Live Labs
                  9:00am - 9:10am10 mins
                  Cell Therapy
                  Opening Remarks from the Chairperson
                  • Miguel Forte - CEO, Bone Therapeutics, Belgium
                  9:00am - 9:10am10 mins
                  Gene Edited Ex Vivo Cell Therapy
                  Opening Remarks from the Chairperson
                  • Miguel Forte - CEO, Bone Therapeutics, Belgium
                  9:00am - 9:10am10 mins
                  In Vivo Gene Therapy
                  Opening Remarks from the Chairperson
                  • Miguel Forte - CEO, Bone Therapeutics, Belgium
                  9:00am - 9:10am10 mins
                  Advanced Tools for Cell and Tissue Manufacturing: 20/20 View
                  Opening Remarks from the Chairperson
                  • Miguel Forte - CEO, Bone Therapeutics, Belgium
                  9:10am - 10:00am50 mins
                  Cell Therapy
                  PANEL: COVID-19: Trailblazers in the CGT Industry
                  • Chris Gemmiti, Ph.D. - SVP of Operations, Sentien Biotechnologies Inc.
                  • Camillo Ricordi - Stacy Joy Goodman Professor of Surgery and Chief, Division of Cellular Transplantation, Distinguished Professor of Medicine, Professor of Biomedical Engineering, Microbiology and Immunology, Director, Diabetes Research Institute and Cell Transplant Center, University of Miami, Fellow, National Academy of Inventors, USA, Member, Italian Supreme Council of Health, USA
                  • Racheli Ofir - Vice President Research & Intellectual Property, Pluristem Therapeutics Inc., Israel
                  • John Lewis Ph.D. - Co-founder and CEO, Aegis Life Inc. and Entos Pharmaceuticals
                  • Lawrence Thompson, Ph.D. - Senior Principal Scientist & Group Leader, Pfizer
                  • Claudia Berrón - Senior Vice President, Business Development and Commercial Operations, BioPharma Production, Avantor
                  9:10am - 10:00am50 mins
                  Gene Edited Ex Vivo Cell Therapy
                  PANEL: COVID-19: Trailblazers in the CGT Industry
                  • Chris Gemmiti, Ph.D. - SVP of Operations, Sentien Biotechnologies Inc.
                  • Camillo Ricordi - Stacy Joy Goodman Professor of Surgery and Chief, Division of Cellular Transplantation, Distinguished Professor of Medicine, Professor of Biomedical Engineering, Microbiology and Immunology, Director, Diabetes Research Institute and Cell Transplant Center, University of Miami, Fellow, National Academy of Inventors, USA, Member, Italian Supreme Council of Health, USA
                  • Racheli Ofir - Vice President Research & Intellectual Property, Pluristem Therapeutics Inc., Israel
                  • John Lewis Ph.D. - Co-founder and CEO, Aegis Life Inc. and Entos Pharmaceuticals
                  • Lawrence Thompson, Ph.D. - Senior Principal Scientist & Group Leader, Pfizer
                  • Claudia Berrón - Senior Vice President, Business Development and Commercial Operations, BioPharma Production, Avantor
                  9:10am - 10:00am50 mins
                  In Vivo Gene Therapy
                  PANEL: COVID-19: Trailblazers in the CGT Industry
                  • Chris Gemmiti, Ph.D. - SVP of Operations, Sentien Biotechnologies Inc.
                  • Camillo Ricordi - Stacy Joy Goodman Professor of Surgery and Chief, Division of Cellular Transplantation, Distinguished Professor of Medicine, Professor of Biomedical Engineering, Microbiology and Immunology, Director, Diabetes Research Institute and Cell Transplant Center, University of Miami, Fellow, National Academy of Inventors, USA, Member, Italian Supreme Council of Health, USA
                  • Racheli Ofir - Vice President Research & Intellectual Property, Pluristem Therapeutics Inc., Israel
                  • John Lewis Ph.D. - Co-founder and CEO, Aegis Life Inc. and Entos Pharmaceuticals
                  • Lawrence Thompson, Ph.D. - Senior Principal Scientist & Group Leader, Pfizer
                  • Claudia Berrón - Senior Vice President, Business Development and Commercial Operations, BioPharma Production, Avantor
                  9:10am - 10:00am50 mins
                  Advanced Tools for Cell and Tissue Manufacturing: 20/20 View
                  PANEL: COVID-19: Trailblazers in the CGT Industry
                  • Chris Gemmiti, Ph.D. - SVP of Operations, Sentien Biotechnologies Inc.
                  • Camillo Ricordi - Stacy Joy Goodman Professor of Surgery and Chief, Division of Cellular Transplantation, Distinguished Professor of Medicine, Professor of Biomedical Engineering, Microbiology and Immunology, Director, Diabetes Research Institute and Cell Transplant Center, University of Miami, Fellow, National Academy of Inventors, USA, Member, Italian Supreme Council of Health, USA
                  • Racheli Ofir - Vice President Research & Intellectual Property, Pluristem Therapeutics Inc., Israel
                  • John Lewis Ph.D. - Co-founder and CEO, Aegis Life Inc. and Entos Pharmaceuticals
                  • Lawrence Thompson, Ph.D. - Senior Principal Scientist & Group Leader, Pfizer
                  • Claudia Berrón - Senior Vice President, Business Development and Commercial Operations, BioPharma Production, Avantor
                  10:00am - 11:00am60 mins
                  Cell Therapy
                  PANEL: Investment in the CGT space: trends, technologies and early stage success
                  • Mike Zhao - Senior Vice President, MSQ Ventures
                  • Jak Knowles - VP Venture Investments, Head of Pharma Investments, Leaps by Bayer
                  • Joey Mason - Head of the Life Sciences Fund, M Ventures, The Netherlands
                  • Dominic Schmidt - Partner, Syncona Investment Management Ltd., UK
                  10:00am - 11:00am60 mins
                  Gene Edited Ex Vivo Cell Therapy
                  PANEL: Investment in the CGT space: trends, technologies and early stage success
                  • Mike Zhao - Senior Vice President, MSQ Ventures
                  • Jak Knowles - VP Venture Investments, Head of Pharma Investments, Leaps by Bayer
                  • Joey Mason - Head of the Life Sciences Fund, M Ventures, The Netherlands
                  • Dominic Schmidt - Partner, Syncona Investment Management Ltd., UK
                  10:00am - 11:00am60 mins
                  In Vivo Gene Therapy
                  PANEL: Investment in the CGT space: trends, technologies and early stage success
                  • Mike Zhao - Senior Vice President, MSQ Ventures
                  • Jak Knowles - VP Venture Investments, Head of Pharma Investments, Leaps by Bayer
                  • Joey Mason - Head of the Life Sciences Fund, M Ventures, The Netherlands
                  • Dominic Schmidt - Partner, Syncona Investment Management Ltd., UK
                  10:00am - 11:00am60 mins
                  Advanced Tools for Cell and Tissue Manufacturing: 20/20 View
                  PANEL: Investment in the CGT space: trends, technologies and early stage success
                  • Mike Zhao - Senior Vice President, MSQ Ventures
                  • Jak Knowles - VP Venture Investments, Head of Pharma Investments, Leaps by Bayer
                  • Joey Mason - Head of the Life Sciences Fund, M Ventures, The Netherlands
                  • Dominic Schmidt - Partner, Syncona Investment Management Ltd., UK
                  11:00am - 11:30am30 mins
                  Cell Therapy
                  Spatially Uniform Cell Growth, pH, and Metabolite Distribution in a Fixed-Bed Bioreactor
                  • Michelle Olson - Senior Scientist, Bioprocess R&D, Pall Biotech, USA
                  11:00am - 11:30am30 mins
                  Gene Edited Ex Vivo Cell Therapy
                  Spatially Uniform Cell Growth, pH, and Metabolite Distribution in a Fixed-Bed Bioreactor
                  • Michelle Olson - Senior Scientist, Bioprocess R&D, Pall Biotech, USA
                  11:00am - 11:30am30 mins
                  In Vivo Gene Therapy
                  Spatially Uniform Cell Growth, pH, and Metabolite Distribution in a Fixed-Bed Bioreactor
                  • Michelle Olson - Senior Scientist, Bioprocess R&D, Pall Biotech, USA
                  11:00am - 11:30am30 mins
                  Advanced Tools for Cell and Tissue Manufacturing: 20/20 View
                  Spatially Uniform Cell Growth, pH, and Metabolite Distribution in a Fixed-Bed Bioreactor
                  • Michelle Olson - Senior Scientist, Bioprocess R&D, Pall Biotech, USA
                  11:30am - 11:50am20 mins
                  Cell Therapy
                  Risk-Based Approaches for Autologous CAR T-Cell Therapy Comparability
                  • Erica Brust - Senior Process Engineer, Juno Therapeutics Inc., USA
                  11:30am - 11:50am20 mins
                  Gene Edited Ex Vivo Cell Therapy
                  Implementation of “off the shelf” Closed Systems fit for every purpose
                  • Ali Mohamed - VP, CMC, Immatics, USA
                  11:30am - 11:50am20 mins
                  In Vivo Gene Therapy
                  Mechanistic Understanding of Recombinant Adeno – Associated Virus Production
                  • Sha Sha - Postdoc, Massachusetts Institute of Technology
                  11:30am - 11:50am20 mins
                  Advanced Tools for Cell and Tissue Manufacturing: 20/20 View
                  Optimization of Cell Culture and Differentiation
                  • Jan Jensen - CEO and Founder, Trailhead Biosystems Inc.
                  11:50am - 12:15pm25 mins
                  Cell Therapy
                  Speaker Q&A - Process Development Considerations & Strategies
                  • Jon A. Rowley, Ph.D. - Founder & Chief Product Officer, RoosterBio Inc.
                  • Erica Brust - Senior Process Engineer, Juno Therapeutics Inc., USA
                  • Rachel Yost - Senior Process Engineer, Juno Therapeutics Inc.
                  • Margarida Serra - Head of Stem Cell Bioengineering Lab, iBET - Instituto de Biologia Experimental e Tecnológica
                  11:50am - 12:15pm25 mins
                  Gene Edited Ex Vivo Cell Therapy
                  Speaker Q&A - Auto vs. Allo Manufacturing & Infrastructure
                  • Ali Mohamed - VP, CMC, Immatics, USA
                  • Philip Lee - COO and Co-Founder, Senti Biosciences
                  • Vadim Klyushnichenko - VP Pharmaceutical Development and Quality, Calibr at Scripps Research
                  • Shyam Patel - Director Business Development, California Institute for Regenerative Medicine
                  11:50am - 12:15pm25 mins
                  In Vivo Gene Therapy
                  Speaker Q&A - High Throughput Applications in Production Platforms & Enabling Manufacturing Tech
                  • Sha Sha - Postdoc, Massachusetts Institute of Technology
                  • Nicole Nuñez, Ph.D., - Process Development Scientist, Eureka Therapeutics, Inc.
                  • Aleš Štrancar - CEO, BIA Separations, Slovenia
                  11:50am - 12:15pm25 mins
                  Advanced Tools for Cell and Tissue Manufacturing: 20/20 View
                  Automated Cell Harvesting Isolation Technologies
                  • Sonia Bulsara - Application Specialist Manager, US & Canada, Cell and Gene Therapy, Cytiva, USA
                  12:15pm - 1:00pm45 mins
                  Cell Therapy
                  Networking Reception
                    12:15pm - 1:00pm45 mins
                    Gene Edited Ex Vivo Cell Therapy
                    Networking Reception
                      12:15pm - 1:00pm45 mins
                      In Vivo Gene Therapy
                      Networking Reception
                        12:15pm - 1:00pm45 mins
                        Advanced Tools for Cell and Tissue Manufacturing: 20/20 View
                        Networking Reception
                          WATCH ON DEMAND: Industry Presentations
                          NextDAY TWO WATCH LIVE (EST); 20/10/20

                          Get the latest news.
                          As it happens

                          Sign up to get the latest on the agenda and speakers.
                          Choose Day